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Abstract 
Treatment with botulinum toxin injections is preferred to microvascular decompression 
surgery therapy, but this injection is only effective in a few months and quite expensive. This study 
is the first study to assess the effectiveness of dry needling on clinical improvement of hemifacial 
spasm compared to standard therapy of botulinum toxin injection. The study design was quasi 
experimental. Total of 24 subjects were divided into two groups. The first group underwent dry 
needling intervention while the other had botulinum injection. Clinical severity before and after 
treatment in both groups was assessed using Jankovic and HFS7 scores. In dry needling group 
there were significant differences between Jankovic and HFS7 score at baseline and at week 1, 2, 
3 and 4. While in botox group significant differences were also Jankovic and HFS7 score at 
baseline and at weeks 2 and 4. There were also a significant difference of Jankovic and HFS7 score 
when we compared dry needling group to botulinum toxin group. Dry needling can be an 
alternative treatment for hemifacial spasm, although clinical improvements based on Jankovic and 
HFS7 scores in dry needling group were not as effective as those with botulinum toxin injections. 
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Introduction 
Hemifacial spasm is a common movement disorder case in daily clinical practice. 
Epidemiological data on hemifacial spasms are quite limited. The average prevalence is 11 per 
100,000 population, 14.5 per 100,000 in women and 7.4 per 100,000 in men. In Germany, the 
brought to you by COREView metadata, citation and similar papers at core.ac.uk




estimated prevalence is 8000 to 9000 people.1 The incidence in women is more than that in men 
with ratio of 2:1. Based on Yaltho and Jankovic study in 2011, out of 215 patients, the ratio of men 
to women was 1:1.8.2 One study in Indonesia also reported that the majority of research subjects 
were women (64,7%).3 Therapeutical management of hemifacial spasm includes oral medications 
such as anticonvulsant drugs, benzodiazepines, baclofen and gabapentin, facial nerve 
decompression surgery and intramuscular injection of botulinum toxin. Oral medication only 
provides mild improvement and there are significant side effects. Surgical treatment with 
microvascular decompression gives 90% success in cases, although it can still be recurrent and 
must be reoperated. Side effects from surgery can also be found including hearing loss, temporary 
or permanent facial nerve damage and intracranial hemorrhage.4 Because of the side effects of oral 
medication and  surgery, botox injection is preferred as long-term treatment of hemifacial spasm 
to drugs or surgery. Some studies even support the use of Botox as a first-line treatment for 
hemifacial spasm. This toxin works by inhibiting the release of acetylcholine in the synaptic cleft, 
causing muscle paralysis.5 Unfortunately, injection with botulinum toxin is only effective in a few 
months, then should be repeated and the cost is quite expensive. Although injection with botulinum 
toxin provide benefits in the management of hemifacial spasm, but this treatment is not very 
popular in Indonesia because of the high cost and the limited coverage of goverment insurance. 
Current techniques are developing on the principle of peripheral and central sensitization. 
One of them is dry needling. This action is widely performed in several countries for myofascial 
pain syndrome management. Myofascial trigger points are tight band muscle nodules caused by 
motor end plate dysfunction in the muscle.6,7 Movement disorders therapy with dry needling 
techniques have never been reported. One case study has reported the success of dry needling 
technique in the management of cervical dystonia.8 This success was assumed to be due to the 
penetration of the needle through the skin to produce physiological effects through the control 
activity of inhibiting various neurotransmitters, and activating the suppression system in the spinal 
cord. 
This is the first study to assess the effectiveness of dry needling in clinical improvement of 
hemifacial spasm compared to standard therapy botulinum toxin injection. This research is part of 




needling compared to botulinum toxin injection in the treatment of hemifacial spasms using 






The design of this study was quasi-experimental while the aim was to assess the 
effectiveness of dry needling and botulinum toxin injections in clinical improvement of hemifacial 
spasms. The population of this study were hemifacial spasm patients who visit neurology clinic at 
RSUP Dr. Moh. Hoesin Palembang from January 2018 to December 2019. All patients diagnosed 
with hemifacial spasm were included in this study, while those who were not willing to participate 
in the study were excluded. The subjects are taken consecutively. Firstly, all hemifacial spasm 
patients are included in dry needling group. The number of subjects in dry needling group was 12. 
Then another 12 patients with similar age and severity with the ones in dry needling group were 
included in the botulinum toxin group. This study has received a certificate of ethics approval from 
the Health Research Ethics Commission of Mohammad Hoesin Hospital and Faculty of Medicine 
Universitas Sriwijaya No. 476/kepkrsmhfkunsri /2019. 
Before intervention, all samples in both groups were interviewed and assessed for the 
Jankovic and HFS7 scores. In dry needling group, the treatment were performed 3 times, at the 
beginning and every two weeks. Evaluation of Jankovic and HFS 7 scores were assessed 1 week 
after and right before each intervention. Evaluation of Jankovic and HFS 7 scores every 1 week 
after each intervention were assessed by telephone or video call for patients who were unable to 
visit the clinic or who live outside the city. In the botulinum toxin group, patients who met the 
inclusion criteria and had performed a matching process to the dry needling group would be also 
interviewed and assessed the Jankovic and HFS7 scores before intervention. Botulinum toxin 
injection was only performed once at the beginning of the study. Then the evaluation of Jankovic 
and HFS 7 scores were assessed every 2 weeks after the intervention. Evaluation for patients which 
live outside the city or were unable to visit the clinic were assessed by telephone or video call. The 




pricked in contracted muscles. The location of needle insertion and the number of needles were 
adjusted to the severity of the contracted muscles. The botulinum toxin injection procedure was 
done by a neurologist. The procedure was carried out by injecting botulinum toxin from the 
pharmaceutical company of Kalbe Farma (Lanzox). The dose and location of the injection were 
adjusted to the severity of the contracted muscles. 
Data analysis was performed using SPSS version 24.0. Paired t-test was conducted to 
compare the difference between Jankovic and HFS7 score at baseline, the second week and the 
fourth week in both groups. Additional analysis were conducted at the first and third weeks in dry 
needling group. Friedman or repeated ANOVA test was used to compare the difference between 
Jankovic and HFS7  score in both groups. 
 
RESULTS 
Table 1 shows that most subjects were female (66.7%), half of the subjects experienced a 
hemifacial spasm for 3-6 years, the location was mostly on the right (75%). Almost all subjects 
experienced clinical severity of Jankovic score 2 (91.7%) and more than half experienced clinical 
severity of severe HFS7 score (58.3%). There was no significant difference in age between the dry 
needling group and the botox injection group. Jankovic and HFS7 severity scores of both groups 
also had no significant difference. 
 






Total  % p 































>6 years 2 1 3 12,5 







































HFS-7 mild (0-9) 
HFS-7moderate(10-18) 



























   
0,514¶ 
0,356* 
*T-test independent, ¶Mann Whitney 
In dry needling group, there were significant differences of Jankovic and HFS7 between baseline 
score and evaluation score at week 1, 2, 3 and 4. While in botox group, significant differences of 
Jankovic and HFS7 scores were also found between baseline score and evaluation score at week 
1, 2 and 4. 
 
Table 2. The mean of Jankovic and HFS-7 score in each Dry Needling and Botulinum Toxin group 




























































HFS-7 20,25  12,33  9,17 0,000* 




Figure 1. Jankovic and HFS7 score in each dry needling and botulinum toxin group  
 
In Friedman's analysis, there was a significant difference of Jankovic score between the dry 
needling group and botulinum toxin group with p value <0,0001. While the analysis of Repeated 
Anova showed a significant difference HFS7 score between both groups with a p value <0,0001. 
 
Table 3. Comparison of Jankovic and HFS-7 score between two groups  










































  *Friedman, ¶Repeated ANOVA 
 
Figure 2. Comparison of Jankovic and HFS-7 score between two groups 
 
Discussion 
This study found that dry needling did not show same effectiveness as standard therapy of 
botox injection in clinical improvement of hemifacial spasms based on Jankovic and HFS7 scores 
assessments. However, this study found significant differences between the Jankovic and HFS7 
baseline scores and the Jankovic and HFS7 evaluation scores in each group. At the time of the 
evaluation, fluctuations were obtained in dry needling procedure. Every 1 week after dry needling 
intervention, a significant clinical improvement was obtained based on Jankovic and HFS7 score 
compared to the baseline score. Even though every 2 weeks after the intervention, the severity 
returned to baseline. Unlike in dry needling group, in botulinum toxin group, Jankovic and HFS7 
scores were declined when evaluated at week 2 and 4. 
The temporary effectiveness of dry needling can be explained by Hsieh et al. study. This 
study showed that if dry needling was performed once a week, it would  give a short-term analgesic 
effect, but if it was performed in 5 cycles for 5 consecutive days, it would maintain the substance 
P (SP) and calcitonin gene-related peptide (CGRP) to remain low. However, after passing through 
the cycle, SP and CGRP will increase, accompanied by a higher TNF-alpha increase, as well as 




hemifacial spasm patients, but this can explain why there were fluctuative clinical improvement 
in the dry needling group in this study. Chandra et al reported one case study of the successful 
management of dry needling in a case of movement disorder, which was cervical dystonia. Dry 
needling that was performed 5 times with 1 week interval showed significant improvement. This 
improvement last up to 6 months.8 
Botulinum toxin injection has been proven effective in the management of dystonic 
movement disorders, such as hemifacial spasms or other focal dystonias. Previous studies have 
also shown significant effectiveness on clinical improvement scores for hemifacial spasm. Karp 
and Alter reported that this injection was effective 76-100% with monitoring of clinical 
improvement for up to 3-4 months. Although clinical improvement is also temporary which is 
about 3-6 months, this procedure is preferred to surgery management. The recurrence time which 
ranges from 3-6 months can be explained by the theory of nerve sprouting which is the second 
phase in the mechanism of action of botulinum toxin.10 
Although the clinical improvement of hemifacial spasms managed by dry needling is not 
as effective as botulinum toxin injection, this intervention in myofacial trigger points are proven 
to reduce muscle contraction in cases of focal dystonia especially hemifacial spasm and dystonia. 
Further research can be carried out by considering the technique and frequency of the dry needling 
cycle which might provide a longer clinical improvement. 
 
Conclusion 
Dry needling can be an alternative management for hemifacial spasm, although clinical 
improvement based on Jankovic and HFS7 scores is not as effective as botulinum toxin injections. 
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